Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (16934)	5/25/2005 5:07:53 PM
From: tuck	Read Replies (1) \| Respond to of 52153

The error is that Genomic Solutions went public five years ago, fizzed out in a couple of years, and was bought for peanuts by Harvard Biosciences, which has announced no plans for trying to spin it back out, and certainly not for $100 million. Everybody saw the error immediately, as HBIO never budged after this "announcement." Maybe some companies with tickers similar to GNSL got a brief bounce, I never looked. Sometimes that sort of thing pays off. Rick played Millenium's munch of Corr Therapeutics (CORR) by daytrading Cortex (COR) for a few minutes, and apparently making some rent money off the trade. Most of us are jealous about that. Cheers, Tuck